C07J
Steroids
Official title: STEROIDS (seco-steroids C07C)
C07J (Steroids) appears on 5,181 US grants and 4,186 published applications in this corpus.
Search patents in C07J- Granted patents
- 5,181
- Published applications
- 4,186
- Assignees
- 2,048
- Inventors
- 10,205
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 169 | 0 |
| 1977 | 142 | 0 |
| 1978 | 117 | 0 |
| 1979 | 72 | 0 |
| 1980 | 147 | 0 |
| 1981 | 127 | 0 |
| 1982 | 102 | 0 |
| 1983 | 65 | 0 |
| 1984 | 98 | 0 |
| 1985 | 74 | 0 |
| 1986 | 83 | 0 |
| 1987 | 58 | 0 |
| 1988 | 53 | 0 |
| 1989 | 86 | 0 |
| 1990 | 100 | 0 |
| 1991 | 76 | 0 |
| 1992 | 97 | 0 |
| 1993 | 79 | 0 |
| 1994 | 63 | 0 |
| 1995 | 107 | 0 |
| 1996 | 130 | 0 |
| 1997 | 138 | 0 |
| 1998 | 149 | 0 |
| 1999 | 111 | 0 |
| 2000 | 100 | 0 |
| 2001 | 96 | 19 |
| 2002 | 103 | 124 |
| 2003 | 88 | 152 |
| 2004 | 89 | 176 |
| 2005 | 65 | 178 |
| 2006 | 86 | 134 |
| 2007 | 64 | 150 |
| 2008 | 58 | 130 |
| 2009 | 63 | 151 |
| 2010 | 81 | 155 |
| 2011 | 76 | 154 |
| 2012 | 92 | 144 |
| 2013 | 91 | 163 |
| 2014 | 120 | 182 |
| 2015 | 127 | 166 |
| 2016 | 139 | 207 |
| 2017 | 151 | 208 |
| 2018 | 135 | 191 |
| 2019 | 166 | 197 |
| 2020 | 154 | 204 |
| 2021 | 137 | 198 |
| 2022 | 96 | 193 |
| 2023 | 97 | 172 |
| 2024 | 86 | 164 |
| 2025 | 119 | 160 |
| 2026 | 59 | 114 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Main groups
Granted patents with any code in the group
- C07J 41/00Normal steroids containing one or more nitrogen atoms not belonging to a1,585
- C07J 9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 171,213
- C07J 1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position1,048
- C07J 43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with966
- C07J 71/00Steroids in which the cyclopentahydrophenanthrene skeleton is condensed with a heterocyclic ring890
- C07J 31/00Normal steroids containing one or more sulfur atoms not belonging to a696
- C07J 51/00Normal steroids with unmodified cyclopentahydrophenanthrene skeleton not provided for in groups c07j1/00601
- C07J 17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero559
All 25 main groupsShow fewer
- C07J 7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17519
- C07J 21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero482
- C07J 5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17433
- C07J 63/00Steroids in which the cyclopentahydrophenanthrene skeleton has been modified by expansion of429
- C07J 53/00Steroids in which the cyclopentahydrophenanthrene skeleton has been modified by condensation with349
- C07J 13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double294
- C07J 73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of250
- C07J 3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17196
- C07J 75/00Processes for the preparation of steroids in general152
- C07J 33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with108
- C07J 19/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17107
- C07J 11/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position80
- C07J 15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially57
- C07J 69/00Steroids in which the cyclopentahydrophenanthrene skeleton has been modified by contraction of37
- C07J 61/00Steroids in which the cyclopentahydrophenanthrene skeleton has been modified by contraction of22
- C07J 65/00Steroids in which the cyclopentahydrophenanthrene skeleton has been modified by contraction of2
- C07J 67/00Steroids in which the cyclopentahydrophenanthrene skeleton has been modified by expansion of0
Recent patents
- Androgen receptor modulators6 Oct 2026US 12,753,202 B2Trustees of Dartmouth College
- Cyclin-dependent kinase inhibitors and methods of use6 Oct 2026US 12,753,203 B2Dana-Farber Cancer Institute, Inc.
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof6 Oct 2026US 12,753,204 B2Enanta Pharmaceuticals, Inc.
- Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer29 Sep 2026US 12,747,263 B2Evestra, Inc.
- Process for isolation of saponins uttroside B and uttroside A from Solanum nigrum linn22 Sep 2026US 12,741,985 B2Council of Scientific and Industrial Research An Indian Registered Body Incorporated Under the Regn. of Soc. Act (Act Xx1 of 1860)
- Steroid-cationic lipid compound and use thereof8 Oct 2026US 2026/0306406 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Oxysterols and methods of use thereof8 Oct 2026US 2026/0308197 A1Sage Therapeutics, Inc.
- Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders8 Oct 2026US 2026/0308198 A1Sage Therapeutics, Inc.
- Spleen-targeted lipid nanoparticles1 Oct 2026US 2026/0294826 A1Beijing Jitai Pharmaceutical Technology Co., Ltd.
- Lipid nanoparticle compositions and uses thereof1 Oct 2026US 2026/0294935 A1Beijing Jitai Life Science Ltd
Most cited
By later US patents
- N-2 substituted purines806US 5,459,255 AIsis Pharmaceuticals, Inc. · 1995
- Sugar modified oligonucleotides that detect and modulate gene expression641US 5,670,633 AIsis Pharmaceuticals, Inc. · 1997
- Oligonucleotides having phosphorothioate linkages of high chiral purity626US 5,587,361 AIsis Pharmaceuticals, Inc. · 1996
- Oligonucleotides containing N-2 substituted purines621US 5,587,469 AIsis Pharmaceuticals, Inc. · 1996
- Substituted purines and oligonucleotide cross-linking603US 5,681,941 AIsis Pharmaceuticals, Inc. · 1997